1. Home
  2. INDP vs JVA Comparison

INDP vs JVA Comparison

Compare INDP & JVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

HOLD

Current Price

$3.03

Market Cap

5.2M

Sector

Health Care

ML Signal

HOLD

JVA

Coffee Holding Co. Inc.

HOLD

Current Price

$3.42

Market Cap

17.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDP
JVA
Founded
2000
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
5.2M
17.8M
IPO Year
2021
1997

Fundamental Metrics

Financial Performance
Metric
INDP
JVA
Price
$3.03
$3.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.6M
89.7K
Earning Date
05-11-2026
06-12-2026
Dividend Yield
N/A
1.71%
EPS Growth
N/A
N/A
EPS
N/A
0.33
Revenue
N/A
$90,655,294.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$10.36
Revenue Growth
N/A
17.54
52 Week Low
$0.92
$2.93
52 Week High
$13.24
$5.62

Technical Indicators

Market Signals
Indicator
INDP
JVA
Relative Strength Index (RSI) 50.20 33.41
Support Level $2.43 $3.28
Resistance Level $3.24 $3.92
Average True Range (ATR) 0.56 0.15
MACD -0.12 0.00
Stochastic Oscillator 10.33 18.11

Price Performance

Historical Comparison
INDP
JVA

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

Share on Social Networks: